IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cocrystal Pharma Inc (COCP)

CUSIP: 19188J409 | NYSE | Healthcare · Biotechnology | Micro Cap | 53 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AOpko Health, Inc.
with Frost Phillip MD ET AL, Frost Gamma Investments Trust, Rubin Steven D
5,692,91629.6%UnchangedNov 4, 2026No 13F filer matched
13D/AOpko Health, Inc.

Institutional Holders — Q3 2026

Geode Capital Management, LLC124,446
0.0% of portfolio›$143.1K
Parallel Advisors, LLC12,569
0.0% of portfolio›$14.5K
Clean Yield Group418
0.0% of portfolio›$481
Nvwm, LLC84
0.0% of portfolio›$97
SBI Securities Co., Ltd.33
0.0% of portfolio›$38
IFP Advisors, Inc13
0.0% of portfolio›$15
Citigroup Inc1
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Geode Capital Management, LLC
124,446$143.1K0.0%IndexVery LowBoston, MA2026-11-06
Parallel Advisors, LLC
12,569$14.5K0.0%GrowthLowSan Francisco, CA2026-11-03
Clean Yield Group
418$4810.0%CoreLowNorwich, VT2026-10-28
Nvwm, LLC
84$970.0%GrowthMediumYardley, PA2026-10-14
SBI Securities Co., Ltd.
33$380.0%GrowthLowTokyo, Mexico2026-10-22
IFP Advisors, Inc
13$150.0%CoreLowTampa, FL2026-10-16
Citigroup Inc
1$10.0%CoreMediumNew York, NY2026-11-04
5,692,916
29.6% of class · Nov 4, 2026Unchanged
with Frost Phillip MD ET AL, Frost Gamma Investments Trust, Rubin Steven D
No 13F filer matched